SGX Market Updates By SGX My Gateway

SGX Market Information

SGX My Gateway Market Updates

Highlights of Singapore’s Three Healthcare REITs

27 April 2017

RHT generated total returns of 2.7% and 33.1% in the year-to-date and last 12 months, bringing its three-year total return to 80.5%. The trust currently trades at 1.1x price-to-book (P/B) ratio with 7.7% dividend yield. Parkway Life generated total returns of 11.0% and 11.1% in the year-to-date and last 12 months, bringing its three-year total return to 21.7%. The trust currently trades at 1.5x price-to-book (P/B) ratio with 5.1% dividend yield. First REIT generated total returns of 9.0% and 14.7% in the year-to-date and last 12 months, bringing its three-year total return to 43.6%. The trust currently trades at 1.3x price-to-book (P/B) ratio with 6.4% dividend yield.

Aoxin Q & M Dental Group – First China Dental Play to List on SGX

SGX My Gateway

25 April 2017

Aoxin Q & M Dental Group Ltd (Aoxin), the first dental services and equipment provider in China, is scheduled to debut on Catalist tomorrow. Aoxin is one of the leading providers of private dental services/dental equipment and supplies in Liaoning Province, Northern China. SGX lists 20 Health Care Equipment and Services stocks with a combined market capitalisation of S$25.0 billion. Excluding secondary listings, these stocks averaged a total return of 17.3% in the YTD.

Pharmaceuticals – A Strong and Growing Healthcare Sub-segment

SGX My Gateway

20 April 2017

Despite being one of Singapore’s smaller healthcare sub-segments, the YTD total return of 7.3% generated by the six Pharmaceuticals stocks is almost double that of the overall SGX Healthcare Index. Against Asia-Pacific peers, Singapore Pharmaceuticals stocks trade at lower valuations of 13.9x PE and 1.2x PB, and generated higher total returns of 7.3% in the YTD (vs 2.2%) and 16.3% in the last one year (vs 7.7%).

21 SG Stocks Feature in Regional Index built on ‘Quality Factors’

SGX My Gateway

17 April 2017

The SGX Developed Asia ex Japan Quality Index is made up of 60 stocks listed across Singapore, Hong Kong and South Korea. With constituents maintaining comparatively strong financials, the Index has generated more resilient long term returns than relative benchmarks. Financial metrics for Quality Factors include net profit margins, return on equity & invested capital, the degree of financial leverage and accrued income.

Strongest Performing Healthcare Providers of the Past Year

SGX My Gateway

13 April 2017

Singapore lists comparatively more stocks in the GICS® ‘Healthcare Providers and Services’ sub-sector than the global norm, with capitalisation growth outpacing the world. Singapore's 14 primary listings in the sub-sector generated a 12 month median return of 24%. Four of the 14 primary listings - Singapore Medical Group, Health Management International, TalkMed Group and Singapore O&G - exceeded 50% in returns over the past 12 months.

Singapore’s High Dividend Yields Grab Spotlight Again

SGX My Gateway

10 April 2017

Singapore’s biggest Index stocks maintain the highest dividend yield in Asia, with Singapore’s yield of 3.7% ranking as Asia’s highest in the FTSE Country Indices. As many as 70% of Singapore’s constituents in the FTSE All-World Index qualify for the FTSE All-World High Dividend Yield Index, compared to the global norm of 40%. Seven of Singapore’s constituents in the FTSE All-World High Dividend Yield Index are also now a part of the One STOXX ASEAN Select Dividend Index and ETF, which launched last week on SGX.

Healthcare Sector Sentiment Remains Positive Despite Slow 1Q

SGX My Gateway

06 April 2017

The SGX All Healthcare index, a benchmark index for Singapore’s listed healthcare companies, generated a total return of 12.7% in the last 12 months, outperforming the regional benchmark MSCI AC Asia ex Japan Healthcare Index’s total return of 0.8%, but lagging the STI’s 10.8%. Singapore’s 10 largest healthcare stocks averaged a 7.3 % return in the 2017 YTD. In calendar year 2016, they averaged a total return of 22.1%. The top three performers YTD are Talkmed Group (+53.4%), Singapore O&G (+11.1%), and Haw Par Corp (+11.0%).

Three Sectors that Continued to Beat the Market in March

SGX My Gateway

04 April 2017

The Information Technology (IT), Materials and Real Estate Management & Development Sectors were again ranked as the best three performing Sectors last month, following the same rankings for the three Sectors in February. Alliance Mineral Assets, China Sunsine Chemical and Kingboard Copper Foil led the Materials Sector Leaders higher in March. Alliance Mineral Assets announced Lithium and Tantalum drilling results in late January and China Sunsine Chemical reported FY2016 profit growth.

Industrial Mining Stocks Made a Solid Start to 2017

SGX My Gateway

30 March 2017

SGX lists four stocks focused on mining Industrial Minerals – Lithium & Tantalite, Phosphate, Limestone and Marble. Mining activities of these stocks span Australia, China and Malaysia. These minerals have diverse industrial applications – from agri-business to construction to health supplements. Three of the four stocks have generated gains in 2017 YTD, with Lithium & Tantalite miner Alliance Mineral Assets the strongest performer of the four. The other two gainers were Marble miner Terratech Group and Limestone miner, GCCP Resources. The median YTD return of the four stocks was 22.3%.

Expansion of the Utility Sector

SGX My Gateway

29 March 2017

The capitalisation of Singapore’s Utility Sector has expanded by 80% over the past five years outpacing the capitalisation growth of the MSCI AC Asia Pacific Utility Index and the parent MSCI AC Asia Pacific Index. Together the 10 stocks of Singapore’s Utility Sector supply water, gas and independent power through renewable electricity production. The 10 stocks have averaged a 5.2% YTD gain, similar to the MSCI AC Asia Pacific Utilities Index which gained 4.3%.

These articles are provided by SGX My Gateway.

SGX My Gateway

SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.

These articles are not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.

Stock / REIT Search

DBS Share Price , Yangzijiang Share Price, Keppel Share Price, Venture Share Price, SingTel Share Price, OCBC Share Price